Determinants of improved one-year survival in non-ST-segment elevation myocardial infarction patients: Insights from the French FAST-MI program over 15 years

International Journal of Cardiology

Volumn 177, Issue 1, 2014, Pages 281-286

  Puymirat, Etienne ^a,b,c   Schiele, François ^d   Steg, Philippe Gabriel ^b,c,e   Blanchard, Didier ^g   Isorni, Marc Antoine ^a,b   Silvain, Johanne ^h   Goldstein, Patrick ⁱ   Guéret, Pascal ^j   Mulak, Geneviève ^k   Berard, Laurence ^l   Bataille, Vincent ^f,m   Cattan, Simon ⁿ   Ferrières, Jean ^f,o   Simon, Tabassome ^f,l,p   Danchin, Nicolas ^a,b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^e BICHAT HOSPITAL   (France)

^f INSERM   (France)

^g Clinique Saint Gatien   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ LILLE UNIVERSITY HOSPITAL   (France)

^j HENRI MONDOR HOSPITAL   (France)

^k Societe Francaise de Cardiologie   (France)

^l HÔPITAL SAINT ANTOINE   (France)

^m TOULOUSE UNIVERSITY HOSPITAL   (France)

ⁿ Department of Cardiology   (France)

^o CHU RANGUEIL   (France)

^p SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

Coronary artery disease; Mortality; Non ST elevation myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FONDAPARINUX; GLYCOPROTEIN IIB INHIBITOR; GLYCOPROTEIN IIIA INHIBITOR; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN INHIBITOR; THIENOPYRIDINE DERIVATIVE; UNCLASSIFIED DRUG; CARDIOVASCULAR AGENT;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; DISEASE REGISTRY; FEMALE; HOSPITAL ADMISSION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; SURVIVAL RATE; CLINICAL TRIAL; ELECTROCARDIOGRAPHY; EPIDEMIOLOGY; FOLLOW UP; FORECASTING; FRANCE; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; PROCEDURES; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; TRENDS;

AGED; CARDIOVASCULAR AGENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FORECASTING; FRANCE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84909943040     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.09.023     Document Type: Article

References (30)

1. W.D. Rosamond, L.E. Chambless, G. Heiss, T.H. Mosley, J. Coresh, and E. Whitsel Twenty-two-year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987-2008 Circulation 125 2012 1848 1857
2. W.J. Rogers, P.D. Frederick, E. Stoehr, J.G. Canto, J.P. Ornato, and C.M. Gibson Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006 Am Heart J 156 2008 1026 1034
3. R.W. Yeh, S. Sidney, M. Chandra, M. Sorel, J.V. Selby, and A.S. Go Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 362 2010 2155 2165
4. K.A. Fox, P.G. Steg, K.A. Eagle, S.G. Goodman, F.A. Anderson Jr, C.B. Granger, and GRACE Investigators Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006 JAMA 297 2007 1892 1900
5. E. Puymirat, T. Simon, P.G. Steg, F. Schiele, P. Guéret, D. Blanchard, USIK USIC 2000 Investigators, and FAST MI Investigators Association of changes in clinical characteristics and management with improvement in survival among patients with ST-elevation myocardial infarction JAMA 308 2012 998 1006
6. M.Y. Chan, J.L. Sun, L.K. Newby, L.K. Shaw, M. Lin, and E.D. Peterson Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction Circulation 119 2009 3110 3117
7. P.G. Steg, R.J. Goldberg, J.M. Gore, K.A. Fox, K.A. Eagle, M.D. Flather, I. Sadiq, and GRACE Investigators Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE) Am J Cardiol 90 2002 358 363
8. D. Hasdai, S. Behar, L. Wallentin, N. Danchin, A.K. Gitt, and E. Boersma A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the Euro Heart Survey of Acute Coronary Syndromes (Euro Heart Survey ACS) Eur Heart J 23 2002 1190 1201
9. N. Danchin, L. Vaur, N. Genès, M. Renault, J. Ferrières, and S. Etienne Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results J Am Coll Cardiol 30 1997 1598 1605
10. G. Hanania, J.P. Cambou, P. Guéret, L. Vaur, D. Blanchard, J-M. Lablanche, and USIC 2000 Investigators Management and in-hospital outcome of patients with acute myocardial infarction admitted to intensive care units at the turn of the century: results from the French nationwide USIC 2000 registry Heart 90 2004 1404 1410
11. J.P. Cambou, T. Simon, G. Mulak, V. Bataille, and N. Danchin The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics Arch Mal Coeur Vaiss 100 2007 524 534
12. M. Hanssen, Y. Cottin, K. Khalife, L. Hammer, P. Goldstein, E. Puymirat, and FAST-MI 2010 Investigators French registry on Acute ST elevation and non ST-elevation Myocardial Infarction 2010: FAST-MI 2010 Heart 98 2012 699 705
13. C.W. Hamm, J.P. Bassand, S. Agewall, J. Bax, E. Boersma, H. Bueno, and ESC Committee for Practice Guidelines ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the task force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC) Eur Heart J 32 2011 2999 3054
14. S.R. Mehta, C.P. Cannon, K.A. Fox, L. Wallentin, W.E. Boden, and R. Spacek Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials JAMA 293 2005 2908 2917
15. A.A. Bavry, D.J. Kumbhani, A.N. Rassi, D.L. Bhatt, and A.T. Askari Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials J Am Coll Cardiol 48 2006 1319 1325
16. Fragmin and Fast Revascularisation During Instability in Coronary Artery Disease Investigators Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study Lancet 354 1999 708 715
17. C.P. Cannon, W.S. Weintraub, L.A. Demopoulos, R. Vicari, M.J. Frey, N. Lakkis, and TACTICS (Treat Angina with Aggrastat and Determine Cost of Therapy with an Invasive or Conservative Strategy) - Thrombolysis in Myocardial Infarction 18 Investigators Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban N Engl J Med 344 2001 1879 1887
18. K.A. Fox, P.A. Poole-Wilson, R.A. Henderson, T.C. Clayton, D.A. Chamberlain, T.R. Shaw, and Randomized Intervention Trial of unstable Angina Investigators Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomized trial. Randomized intervention of unstable angina Lancet 360 2002 743 751
19. R.J. de Winter, F. Windhausen, J.H. Cornel, P.H. Dunselman, C.L. Janus, P.E. Bendermacher, and Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators Early invasive versus selectively invasive management for acute coronary syndromes N Engl J Med 353 2005 1095 1104
20. K.A. Fox, T.C. Clayton, P. Damman, S.J. Pocock, R.J. de Winter, and J.G. Tijssen FIR Collaboration. Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome: a meta-analysis of individual patient data J Am Coll Cardiol 55 2010 2435 2445
21. E. Puymirat, G. Taldir, N. Aissaoui, G. Lemesle, L. Lorgis, and T. Cuisset Use of invasive strategy in non-ST-segment elevation myocardial infarction is a major determinant of improved long-term survival: FAST-MI (French Registry of Acute Coronary Syndrome) JACC Cardiovasc Interv 5 2012 893 902
22. G. Montalescot, G. Cayla, J.P. Collet, S. Elhadad, F. Beygui, H. Le Breton, and ABOARD Investigators Immediate vs. delayed intervention for acute coronary syndromes: a randomized clinical trial JAMA 302 2009 947 954
23. S.R. Mehta, C.B. Granger, W.E. Boden, P.G. Steg, J.P. Bassand, D.P. Faxon, and TIMACS Investigators Early versus delayed invasive intervention in acute coronary syndromes N Engl J Med 360 2009 2165 2175
24. D.G. Katritsis, G.C. Siontis, A. Kastrati, A.W. van't Hof, F.J. Neumann, and K.C. Siontis Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes Eur Heart J 32 2011 32 40
25. J. Silvain, F. Beygui, O. Barthélémy, C. Pollack Jr, M. Cohen, and U. Zeymer Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis BMJ 344 2012 e553
26. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
27. S.D. Wiviott, E. Braunwald, C.H. McCabe, G. Montalescot, W. Ruzyllo, S. Gottlieb, and TRITON-TIMI 38 Investigators Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2007 2001 2015
28. L. Wallentin, R.C. Becker, A. Budaj, PLATO Investigators, A. Freij, and M. Thorsén Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 2009 1045 1057
29. S.A. Murphy, C.P. Cannon, S.D. Wiviott, C.H. McCabe, and E. Braunwald Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy - Thrombolysis In Myocardial Infarction 22) trial J Am Coll Cardiol 54 2009 2358 2362
30. J.A. de Lemos, M.A. Blazing, S.D. Wiviott, E.F. Lewis, K.A. Fox, H.D. White, and Investigators Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial JAMA 292 2004 1307 1316